Advanced filters
News
In December 2020 AMO- Pharma announced the initiation of the Phase 2/3 clinical trial, REACH-CDM.…
News
This includes the way new medicines are regulated, arrangements for reciprocal healthcare rights,…
News
As you are aware, the current MAA for ataluren (Translarna) is scheduled to end in July 2021. NICE…
News
In early December, Muscular Dystrophy UK and SMA UK reported our disappointment that, despite the…
News
Muscular Dystrophy UK has submitted a consultation response to a Methods Review by the National…
News
These include the first ever national Standards of Care for adults with DMD and the expansion of…
News
This was due to the results from an interim analysis of a clinical trial called SIDEROS, which led…
News
These include the first ever national Standards of Care for adults with DMD and the expansion of…
News
Muscular Dystrophy UK welcomes today’s development. It means adult patients in Scotland will be…
News
We recently posted a blog from Rob Burley, MDUK’s Director for Campaigns, Care and Support, on a…